Compare PAYC & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PAYC | DVA |
|---|---|---|
| Founded | 1998 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Misc Health and Biotechnology Services |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.9B | 8.2B |
| IPO Year | 2014 | 1995 |
| Metric | PAYC | DVA |
|---|---|---|
| Price | $149.04 | $106.59 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 4 |
| Target Price | ★ $217.15 | $145.00 |
| AVG Volume (30 Days) | 783.3K | ★ 813.3K |
| Earning Date | 02-11-2026 | 02-12-2026 |
| Dividend Yield | ★ 1.02% | N/A |
| EPS Growth | N/A | ★ 5.63 |
| EPS | 8.05 | ★ 9.76 |
| Revenue | $2,001,300,000.00 | ★ $13,317,965,000.00 |
| Revenue This Year | $11.03 | $6.50 |
| Revenue Next Year | $8.80 | $2.97 |
| P/E Ratio | $18.32 | ★ $10.64 |
| Revenue Growth | ★ 9.72 | 5.14 |
| 52 Week Low | $145.61 | $101.00 |
| 52 Week High | $267.76 | $179.60 |
| Indicator | PAYC | DVA |
|---|---|---|
| Relative Strength Index (RSI) | 33.17 | 36.93 |
| Support Level | $145.61 | $103.48 |
| Resistance Level | $159.30 | $106.38 |
| Average True Range (ATR) | 4.08 | 3.15 |
| MACD | -0.57 | -0.51 |
| Stochastic Oscillator | 23.44 | 37.21 |
Founded in 1998, Paycom is a human capital management software-as-a-service provider addressing customer requirements surrounding payroll, talent acquisition, talent management, HR management, as well as time and labor. The company primarily services midsize businesses within the United States, targeting businesses with 50-10,000 employees. The company primarily generates revenue through the sale of subscriptions providing access to its HCM platform. To a lesser extent, the company also generates revenue from implementation services provided to customers as well as interest income generated from customer funds. As of fiscal 2024, the company serviced slightly over 37,500 customers and stored data on over 7 million employees.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.